Aquestive Therapeutics, Inc. (AQST)
USD 2.52
(2.02%)
USD 2.52
(2.02%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -6.38 Million | -9.78 Million | -32.97 Million | -45.45 Million | -60.21 Million | -12.99 Million |
| Net Income | -7.87 Million | -54.41 Million | -70.53 Million | -55.78 Million | -66.24 Million | -61.37 Million |
| Depreciation & Amortization | 1.34 Million | 2.38 Million | 2.96 Million | 3.44 Million | 2.9 Million | 3.23 Million |
| Deferred income taxes | 2 Million | - | 13.82 Million | - | 4.89 Million | 5.28 Million |
| Stock-based compensation | 2.68 Million | 4.38 Million | 6.81 Million | 6.58 Million | 7.07 Million | 29.94 Million |
| Change in working capital | -5.34 Million | 32 Million | -1.73 Million | -4.41 Million | -11.12 Million | 7.99 Million |
| Other non-cash items | 788 Thousand | 5.84 Million | 15.68 Million | 4.71 Million | 2.28 Million | 1.93 Million |
| Investing Cash Flow | -995 Thousand | -2.52 Million | -913 Thousand | -517 Thousand | -663 Thousand | -1.82 Million |
| Investments in PPE | -995 Thousand | -2.52 Million | -913 Thousand | -517 Thousand | -663 Thousand | -1.82 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -995 Thousand | -1.5 Million | - | - | - | - |
| Financing Cash Flow | 3.97 Million | 11.56 Million | 30.1 Million | 28.45 Million | 49.6 Million | 58.03 Million |
| Debt repayment | -27.13 Million | -2.02 Million | - | -24.75 Million | -52.94 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -11 Thousand | -3000.00 | -14 Thousand | -99 Thousand | -2.82 Million | -6.02 Million |
| Common Stock Issuance | 17.25 Million | 13.55 Million | 29.78 Million | 6.21 Million | 39.31 Million | 68.71 Million |
| Other Financing Activities | 13.84 Million | 37 Thousand | 343 Thousand | 47.19 Million | 68.88 Million | -10.67 Million |
| Accounts receivables | -3.07 Million | 7.35 Million | -4.93 Million | 1.2 Million | -7.43 Million | -409 Thousand |
| Accounts payables | -1.02 Million | 1.63 Million | 1.22 Million | -5.18 Million | -7.87 Million | 11.31 Million |
| Inventory | -989 Thousand | -1.74 Million | -1.57 Million | 398 Thousand | 2.58 Million | -1.42 Million |
| Other working capital | -259 Thousand | 24.76 Million | 3.56 Million | -828 Thousand | 1.6 Million | -1.48 Million |
| Cash at beginning of period | 27.27 Million | 28.02 Million | 31.8 Million | 49.32 Million | 60.59 Million | 17.37 Million |
| Cash at end of period | 23.87 Million | 27.27 Million | 28.02 Million | 31.8 Million | 49.32 Million | 60.59 Million |
| Capital Expenditure | -995 Thousand | -2.52 Million | -913 Thousand | -517 Thousand | -663 Thousand | -1.82 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -3.4 Million | -751 Thousand | -3.78 Million | -17.51 Million | -11.27 Million | 43.22 Million |
| Free Cash Flow | -7.37 Million | -12.31 Million | -33.89 Million | -45.97 Million | -60.87 Million | -14.81 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -11.5 Million | -2.74 Million | -12.82 Million | -8.11 Million | -7.87 Million | -2.03 Million |
| Depreciation & Amortization | 159 Thousand | 205 Thousand | 207 Thousand | 467 Thousand | 1.34 Million | 263 Thousand |
| Deferred income taxes | - | - | - | -2.52 Million | 2 Million | - |
| Stock-based compensation | 1.57 Million | 1.53 Million | 1.58 Million | 940 Thousand | 2.68 Million | 774 Thousand |
| Change in working capital | 10.4 Million | -8.36 Million | -2.04 Million | -1.1 Million | -5.34 Million | -1.43 Million |
| Other non-cash items | -12.51 Million | 4.21 Million | 4.23 Million | 5.39 Million | 788 Thousand | 88 Thousand |
| Investing Cash Flow | -80 Thousand | -35 Thousand | -29 Thousand | -16 Thousand | -995 Thousand | -151 Thousand |
| Investments in PPE | -80 Thousand | -35 Thousand | -29 Thousand | -16 Thousand | -995 Thousand | -151 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -35 Thousand | - | - | - | - |
| Financing Cash Flow | -17 Thousand | 1.71 Million | 81.74 Million | 3.91 Million | 3.97 Million | 4.97 Million |
| Debt repayment | -8000.00 | -5000.00 | -5000.00 | -14.58 Million | -27.13 Million | -1.02 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 898 Thousand | -5000.00 | -893 Thousand | 11 Thousand | -11 Thousand | - |
| Common Stock Issuance | -72.54 Million | 1.72 Million | 82.63 Million | 3.61 Million | 17.25 Million | 184 Thousand |
| Other Financing Activities | 71.63 Million | -5000.00 | -893 Thousand | 14.88 Million | 13.84 Million | 5.81 Million |
| Accounts receivables | -2.48 Million | 2.33 Million | 147 Thousand | 104 Thousand | -3.07 Million | 2.13 Million |
| Accounts payables | 1.87 Million | -3.01 Million | 1.28 Million | -1.06 Million | -1.02 Million | -695 Thousand |
| Inventory | -55 Thousand | 768 Thousand | -965 Thousand | 310 Thousand | -989 Thousand | -1.12 Million |
| Other working capital | 10.96 Million | -8.45 Million | -2.51 Million | -446 Thousand | -259 Thousand | -1.74 Million |
| Cash at beginning of period | 89.87 Million | 95.2 Million | 23.87 Million | 24.91 Million | 27.27 Million | 22.43 Million |
| Cash at end of period | 77.89 Million | 89.87 Million | 95.2 Million | 23.87 Million | 23.87 Million | 24.91 Million |
| Capital Expenditure | -80 Thousand | -35 Thousand | -29 Thousand | -16 Thousand | -995 Thousand | -151 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -11.97 Million | -5.33 Million | 71.32 Million | -1.04 Million | -3.4 Million | 2.48 Million |
| Free Cash Flow | -11.96 Million | -7.04 Million | -10.41 Million | -4.95 Million | -7.37 Million | -2.49 Million |
RFLL
GENE
QIAN
SGMT
ALEGF
SXYAY